Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Larson

Showing results (271-280 of 329) with videos related to

Pageof 33
Sort By:
Cancer Research|June 1, 1987
[125I]17-alpha-iodovinyl 11-beta-methoxyestradiol interaction in vivo with estrogen receptors in hormone-independent MCF-7 human breast cancer transfected with the v-rasH oncogeneM E McManaway, E M Jagoda, A Kasid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1981
Positron imaging feasibility studies. I: Characteristics of [3H]thymidine uptake in rodent and canine neoplasms: concise communicationS M Larson, P L Weiden, Z Grunbaum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1981
Positron imaging feasibility studies. II: Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communicationS M Larson, P L Weiden, Z Grunbaum, et al.
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of ageN K Cheung, B H Kushner, I Y Cheung, et al.
Neurosurgery|June 1, 1987
Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous systemE A Neuwelt, H D Specht, P A Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphomaM S Czuczman, D J Straus, C R Divgi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, C R Divgi, N Kemeny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinomaR J Wong, D T Lin, H Schöder, et al.
European Journal of Nuclear Medicine|May 1, 1993
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in gliomaF Daghighian, K S Pentlow, S M Larson, et al.
Pageof 33

Showing results (271-280 of 329) with videos related to

Sort By:
Pageof 33
Cancer Research|June 1, 1987
[125I]17-alpha-iodovinyl 11-beta-methoxyestradiol interaction in vivo with estrogen receptors in hormone-independent MCF-7 human breast cancer transfected with the v-rasH oncogeneM E McManaway, E M Jagoda, A Kasid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1981
Positron imaging feasibility studies. I: Characteristics of [3H]thymidine uptake in rodent and canine neoplasms: concise communicationS M Larson, P L Weiden, Z Grunbaum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1981
Positron imaging feasibility studies. II: Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communicationS M Larson, P L Weiden, Z Grunbaum, et al.
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of ageN K Cheung, B H Kushner, I Y Cheung, et al.
Neurosurgery|June 1, 1987
Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous systemE A Neuwelt, H D Specht, P A Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphomaM S Czuczman, D J Straus, C R Divgi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancerS Welt, C R Divgi, N Kemeny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinomaR J Wong, D T Lin, H Schöder, et al.
European Journal of Nuclear Medicine|May 1, 1993
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in gliomaF Daghighian, K S Pentlow, S M Larson, et al.
Pageof 33